Delivery Order SPE2DB22D1017-SPE2DB25FF7PH
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,920.00 firm fixed price delivery order is for the supply of PROGRAF 1 MG CAPSULE 100S. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price valued at $1,522.32 and a performance period through November 6, 2024. The contract is for the supply of PROGRAF 1 MG CAPSULE 100S, a pharmaceutical product, and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,252.35 firm fixed-price delivery order is for the supply of PROGRAF 5 MG CAPSULE 100S, a pharmaceutical product. The contract has a period of performance through May 28, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,640.00, is a Delivery Order under DLA's Indefinite Delivery Contract (IDC) with AmerisourceBergen, which has a ceiling of $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical...
- The U.S. Defense Logistics Agency (DLA) awarded a $11,912.25 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide PROGRAF 1 MG CAPSULE 100S to support federal healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to military treatment facilities worldwide....
- This federal contract award, with ID SPE2DX15D1022|SPE2DX24FVMRG, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,460.00 firm fixed price delivery order is for the supply of PROGRAF 1 MG CAPSULE 100S, a critical pharmaceutical product. This contract has no set-aside designation and is scheduled for completion by August 30, 2024. Amerisourcebergen, through its Corporate Office...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 100 units of the pharmaceutical product PROGRAF 1 MG CAPSULE. The $1,640.00 order has a completion date of February 9, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to deliver a broad...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $3,280.00 firm-fixed-price delivery order is for the supply of 4,565,815,730 units of the immunosuppressant drug Prograf 1 mg capsules. The contract has a period of performance through September 12, 2024 and does not utilize any set-aside designations. Amerisourcebergen is a major pharmaceutical distributor that provides a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for Prograf 1 mg capsules. The contract has a ceiling value of $1,454.98 and is a firm fixed price contract type. The place of performance is Conshohocken, Pennsylvania. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities...
- The federal contract award, valued at $12,794.37, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FF7PHDelivery Order
This federal contract award, valued at $8,855.13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for PROGRAF 1 MG CAPSULE 100S, with an ultimate completion date of March 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. Additionally, AmerisourceBergen maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. This contract award did not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.9k | 3/12/25 |